De novo inflammatory bowel diseases after liver transplantation: Description of four new cases and a review of the literature;Maladies inflammatoires cryptogéniques de l'intestin de novo après transplantation hépatique: Rapport de quatre nouveaux cas et revue de la littérature

Gastroenterologie Clinique et Biologique

Volumn 30, Issue 8-9, 2006, Pages 1096-1101

  Vu, Francis ^a   Maillard, Michel ^b   Pascual, Manuel ^a   Michetti, Pierre ^a   Felley, Christian ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ALCOHOL LIVER CIRRHOSIS; CASE REPORT; CLINICAL FEATURE; CROHN DISEASE; ENTERITIS; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MONOTHERAPY; REVIEW; SCLEROSING CHOLANGITIS; ULCERATIVE COLITIS;

EID: 33750718506     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-8320(06)73484-4     Document Type: Review

References (27)

1. Bouma G, Strober W. The immunologic and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;3:521-33.
2. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347:417-29.
3. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995;332:924-33.
4. Seibold F, Slametschka D, Gregor M, Weber P. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis sclerosing cholangitis. Gastroenterology 1994;107:532-6.
5. Brandtzaeg P. Autoimmunity and ulcerative colitis: can two enigmas make sense together? Gastroenterology 1996;109:307-12.
6. Harrison J, McMaster P. The role of orthotopic liver transplantation in the management of sclerosing cholangitis. Hepatology 1994;20:14S-9.
7. Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL. Liver transplantation for sclerosing cholangitis. Hepatology 1995;22:451-7.
8. Riley TR, Schoen RE, Lee RG, Rakela J. A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease. Am J Gastroenterol 1997;92:279-82.
9. Cuoco L, Tursi A, Cammarota G, Papa A, Fedeli G, Gasbarini G. On-set of ulcerative colitis during immunosuppressive therapy for liver transplantation. Am J Gastroenterol 1997;92:2134-5.
10. Ramji A, Owen DA, Erb SR, Scudamore CH, Yoshida EM. Post-liver transplant Crohn's disease graft tolerance but not self tolerance? Dig Dis Sci 2002;47:522-7.
11. Befeler AS, Lissoos TW, Schiano TD, Conjeevaram H, Dasgupta KA, Millis JM, et al. Clinical course and management of inflammatory bowel disease after liver transplantation. Transplantation 1998;65:393-6.
12. Passfall J, Distler A, Riecken EO, Zeitz M. Development of ulcerative colitis under the immunosuppressive effect of cyclosporine. Clin Invest 1992;70:611-3.
13. Wong NACS, Bathgate AJ, Bellamy COC. Colorectal disease in liver allograft recipients - a clinicopathological study with follow-up. Eur J Gastroenterol Hepatol 2002;14:231-6.
14. Papatheodoridis GV, Hamilton M, Mistry PK, Davidson B, Rolles K. Ulcerative colitis has an agressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut 1998;43:639-44.
15. Shaked A, Colonna JO, Goldstein A, Busuttil RW. The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation. Ann Surg 1992;215:598-605.
16. Hanauer SB, Dassapoulos T. Evolving treatment strategies in inflammatory bowel disease. Annu Rev Med 2001;52:299-318.
17. Sandborn WJ. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate. Am J Gastroenterol 1996;91:423-33.
18. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Commitee. Am J Gastroenterol 2004;99:1371-85.
19. Bowen JRC, Sahi S. Cyclosporin induced colitis. Br Med J 1993;307:484.
20. Roberts JP, Ascher NL, Lake J, Capper J, Purohit S, Garovoy M, et al. Graft vs. Host disease after liver transplantation in humans: a report of four cases. Hepatology 1991;14:274-81.
21. Dumortier J, Slim R, Scoazec J-Y, Boillot O, Berger F, Mion F, et al. Apparition d'une rectocolite hémorragique après transplantation hépatique pour cirrhose alcoolique. Gastroenterol Clin Biol 2000;24:137.
22. Nelson RP, Ballow M. Immunomodulation and immunotherapy: Drugs, cytokines, cytokine receptors and antibodies. J allergy Clin Immunol 2003;111:S720-32.
23. Kornbluth A. Is there still a role for cyclosporine in the treatment of inflammatory bowel disease? Pro argument. Inflamm Bowel Dis 2003;9:194-7.
24. Fellermann K, Lühmann D, Stange EF. Is there still a role for cyclosporine in the treatment of inflammatory bowel disease? Con argument. Inflamm Bowel Dis 2003;9:198-201.
25. Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporine in ulcerative colitis: a 5-year experience. Am J Gastroenterol 1999;94:1587-92.
26. Raimondo ML, Burroughs AK. Single-agent immunosuppression after liver transplantation. What is possible? Drugs 2002;62:1587-97.
27. Rolles K, Davidson BR, Burroughs AK. A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporine. Transplantation 1999;68:1195-8.